Skye Medicine (Shanghai) Co.

BiotechnologySeedShanghai, China

Latest round

Seed

Last raised

Mar 2026

Total raised

$15M

Investors

5

About Skye Medicine (Shanghai) Co.

, Ltd. provides cell immunotherapy research and development for the biotechnology industry. The company builds technical platforms to create in vivo therapies and autologous cell processing methods. The firm currently provides its medical research capabilities to the healthcare sector in China. The Founder is Dr. Wen Wang, who has experience in the clinical development and commercialization of CAR-T cell products. The company works with the healthcare and pharmaceutical sectors to provide cell immunotherapy solutions. The company generates revenue from the research, development and commercialization of its biological medical products.

Who invested in Skye Medicine (Shanghai) Co.

5 investors across 1 round

See all investors in Skye Medicine (Shanghai) Co.

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Mar 19, 2026

    Amount

    $15M

    Investors

    Locked

Questions about Skye Medicine (Shanghai) Co.

Who invested in Skye Medicine (Shanghai) Co.?

Skye Medicine (Shanghai) Co. has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Skye Medicine (Shanghai) Co. raised?

Skye Medicine (Shanghai) Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Skye Medicine (Shanghai) Co. last raise money?

Skye Medicine (Shanghai) Co.'s most recent round on record is a Seed, in Mar 2026.

What does Skye Medicine (Shanghai) Co. do?

Skye Medicine (Shanghai) Co. is a biotechnology company.

Where is Skye Medicine (Shanghai) Co. headquartered?

Skye Medicine (Shanghai) Co. is headquartered in Shanghai, China.

Which VCs invest in companies like Skye Medicine (Shanghai) Co.?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Skye Medicine (Shanghai) Co.'s stage. Their profiles are linked below.

Raising like Skye Medicine (Shanghai) Co.? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.